CARBIDOPA AND LEVODOPA 100 mg/1

Carbidopa and Levodopa 100 mg/1 extended-release tablets are used to treat Parkinson's disease symptoms. This combination medication helps manage movement and tremors by increasing dopamine levels in the brain.

Carbidopa and Levodopa 100 mg/1 extended-release tablets are primarily used to treat the symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty moving. The medication works by increasing the levels of dopamine, a chemical messenger in the brain that is often low in people with Parkinson's disease. This helps to improve movement and reduce symptoms. Carbidopa and Levodopa 100 mg/1 extended-release tablets are designed to provide a steady release of the medication over an extended period, which can help to maintain consistent levels of dopamine in the brain throughout the day.

Common effects of Carbidopa and Levodopa 100 mg/1 extended-release tablets may include nausea, dizziness, and headache. Some users may also experience drowsiness, dry mouth, or constipation. These effects are usually mild and temporary, but if they persist or become severe, it is important to consult a healthcare professional.

Carbidopa and Levodopa 100 mg/1 extended-release tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight and heat. Keep the medication out of reach of children and pets. Do not crush or chew the extended-release tablets, as this can affect the way the medication is released into the body.

Carbidopa and Levodopa 100 mg/1 extended-release tablets may interact with other medications, including certain antidepressants, antipsychotics, and blood pressure medications. It is important to inform your healthcare professional about all the medications you are taking before starting Carbidopa and Levodopa 100 mg/1 extended-release tablets. Additionally, consuming alcohol while taking this medication may increase the risk of side effects.